Frequent p53 mutations and occasional loss of chromosome 4 in invasive bladder carcinoma induced by N-butyl-N-(4-hydroxybutil)nitrosamine in B6D2F1 mice

Molecular Carcinogenesis

Volumn 21, Issue 1, 1998, Pages 70-79

  Ogawa, Kumiko ^a,b   Uzvolgyi, Éva ^a   St John, Margaret K ^a   De Oliveira, Maria Luiza ^a,c   Arnold, Lora ^a   Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bladder cancer; Cancer genetics; Suppressor genes

Indexed keywords

N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER INVASION; CHROMOSOME LOSS; CONTROLLED STUDY; GENE MUTATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; CARCINOMA; CHROMOSOME DELETION; HUMANS; MALE; MICE; MUTATION; TUMOR SUPPRESSOR PROTEIN P53; URACIL; URINARY BLADDER NEOPLASMS;

ANIMALIA; RODENTIA;

EID: 0031885711     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199801)21:1<70::AID-MC9>3.0.CO;2-T     Document Type: Article

References (40)

1. Ito N, Hiasa Y, Tamai A, Okajima E, Kitamura H. Histogenesis of. urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 60:401-410, 1969.
2. Akagi G, Akagi A, Kimura M, Otsuka H. Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 64:331-336, 1973.
3. Ertürk E, Price JM, Morris JE, et al. The production of carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 27:1998-2002, 1967.
4. Cohen SM, Ellwein LB, Okamura T, et al. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cancer Res 51:1766-1777, 1991.
5. Fukushima S, Tanaka H, Asakawa E, Kagawa M, Yamamoto A, Shirai T. Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale. Cancer Res 52:1675-1680, 1992.
6. Ertürk E, Cohen SM, Bryan GT. Urinary bladder Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in female Swiss mice. Cancer Res 30:1309-1311, 1970.
7. 1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 41:927-932, 1981.
8. Asamoto M, Mann AM, Cohen SM. p53 mutation is infrequent and might not give a growth advantage in rat bladder carcino- genesis in vivo. Carcinogenesis 15:455-458, 1994.
9. Masui T, Don I, Takada N, Ogawa K, Shirai T, Fukushima S. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 15:2379-2381, 1994.
10. Jones RF, Matuszyk J, Debiec-Rychter M, Wang CY. Mutation and altered expression of p53 genes in experimental rat bladder tumor cells. Mol Carcinog 9:95-104, 1994.
11. Yamamoto S, Masui T, Murai T, et al. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 16:2363-2368, 1995.
12. Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 152:706-709, 1991.
13. Fujimoto K, Yamada Y, Okajima E, et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52:1393-1398, 1992.
14. Kusser WC, Miao X, Glickman BW, et al. p53 mutations in human bladder cancer. Environ Mol Mutagen 24:156-160, 1994.
15. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54:640-642, 1994.
16. Van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158, 1994.
17. Huang DP, Lo K-W, Van Hasselt CA, et al: A lesion of homozy- gous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54:4003-4006, 1994.
18. Cairns P, Tokino K, Eby Y, Sidransky D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55:224-227, 1995.
19. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 54:531-538, 1994.
20. Cairns P, Tokino K, Eby Y, and Sidransky D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54:1422-1424, 1994.
21. Stadler WM, Sherman J, Bohlander SK, et al. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060-2063, 1994.
22. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, CordonCardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54:2848-2851, 1994.
23. Devlin J, Keen AJ, Knowles MA. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA. Oncogene 9:2757-2760, 1994.
24. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993.
25. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440, 1994.
26. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756, 1994.
27. INK4b genes. Oncogene 11:635-645, 1995.
28. Copeland NG, Jenkins NA, Gilbert DJ, et al. A genetic linkage map of the mouse: Current applications and future prospects. Science 262:57-66, 1993.
29. 1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci USA 91:3759-3763, 1994.
30. Herzog CR, Wiseman RW, You M. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res 54:4007-4010, 1994.
31. Nishimori H, Ogawa K, Tateno H. Frequent deletion in chromosome 4 and duplication of chromosome 15 in liver epithelial cells derived from long-term culture of C3H mouse hepatocytes. Int J Cancer 59:108-113, 1994.
32. Miyasaki K, Ohtake K, Nomura K, et al. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 13:37-43, 1995.
33. McCormick DL, Ronan SS, Becci PJ, and Moon RC. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 2:251-254, 1981.
34. Cohen SM. Pathology of experimental bladder cancer in rodents. In: Bryan GT, Cohen SM (eds), The Pathology of Bladder Cancer, Vol II. CRC Press, Boca Raton, FL, pp. 1-40, 1983.
35. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC, Lander ES. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131:423-447, 1992.
36. Shirai T, Ikawa E, Fukushima S, Masui T, Ito N. Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. Cancer Res 46:2062-2067, 1986.
37. Sakata T, Masui T, St John M, and Cohen SM. Uracil-induced calculi and proliferate lesions of the mouse urinary bladder. Carcinogenesis 9:1271-1276, 1988.
38. Taylor JA, Li Y, He M, et al. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res 55:294-298, 1996.
39. 6-(4-hydroxybutyl)guanine in urothelial and hepatic DNA of rats given the bladder carcinogen N-nitrosobutyl(4hydroxybutyl)amine. Carcinogenesis 15:2297-2301, 1994.
40. Spruck III CH, Ohneseit PF, Gonzalez-Zulueta M, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-788, 1994.